Abstract:In this study, we found that Siglec‐1 expression on monocytes correlates with the interferon score. In our setting, Siglec‐1 expression can reveal interferon inflammation in rheumatological disorders and in infections, even with normal erythrocyte sedimentation rate or C‐reactive protein. Moreover, we highlighted, with in vitro studies, the significance of percentage of positive cells compared with median fluorescence intensity of Siglec‐1. Objectives Inflammatory markers such as erythrocyte sedimentation rate (ESR) and C‐reactive protein (CRP) are poorly informative about interferon (IFN)‐related disorders. In these conditions, the measure of the interferon score (IS), obtained by measuring the expression of IFN‐stimulated genes, has been proposed. Flow cytometry‐based assays measuring sialic‐acid‐binding Ig‐like lectin 1 (Siglec‐1) expression could be a more practical tool for evaluating IFN‐inflammation. The study compared Siglec‐1 measures with IS and other inflammatory indexes. We compared Siglec‐1 measures with IS and other inflammatory indexes in real‐world paediatric rheumatology experience. Methods We recruited patients with immuno‐rheumatological conditions, acute infectious illness and patients undergoing orthopaedic surgery as controls. Siglec‐1 expression was measured in all samples, and IS, ESR and CRP were also recorded if available. Results Overall, 98 subjects were enrolled in the study, with a total of 104 measures of Siglec‐1. Compared with IS, Siglec‐1 expression showed good accuracy (86.0%), specificity (72.7%) and sensitivity (85.7%). The measure of the percentage of Siglec‐1‐positive cells performed best at low levels of IFN‐inflammation, while the measure of mean fluorescence intensity performed best at higher levels. Ex vivo studies on IFN‐stimulated monocytes confirmed this behaviour. There was no link between Siglec‐1 expression and either ESR or CRP, and positive Siglec‐1 results were found even when ESR and CRP were normal. A high Siglec‐1 expression was also recorded in subjects with acute infections. Conclusion Siglec‐1 measurement by flow cytometry is an easy tool to detect IFN‐related inflammation, even in subjects with normal results of common inflammation indexes.

Siglec‐1, an easy and contributory inflammation marker in rheumatology

Increased Expression of Siglec-1 on Peripheral Blood Monocytes and Its Role in Mononuclear Cell Reactivity to Autoantigen in Rheumatoid Arthritis.

SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome

Clinical significance of serum sICAM-1 and sE-selectin in patients with active rheumatoid arthritis

Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response

Monocyte surface expression of Fcγ receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus

Soluble signal inhibitory receptor on leukocyte-1 reflects disease activity and assists diagnosis of patients with rheumatoid arthritis

Soluble Signal Inhibitory Receptor on Leukocytes-1 Reflects Disease Activity and Assists Diagnosis of Patients with Rheumatoid Arthritis.

Siglec-1 on Monocytes is a Potential Risk Marker for Monitoring Disease Severity in Coronary Artery Disease

Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression

Siglec-9 is Upregulated in Rheumatoid Arthritis and Suppresses Collagen-Induced Arthritis Through Reciprocal Regulation of Th17-/Treg-cell Differentiation.

Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study

Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren’s syndrome

Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options

Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis

The diagnostic role of the systemic inflammation index in patients with immunological diseases: a systematic review and meta-analysis

Significance of inflammatory biomarkers in clinical diagnostics: Erythrocyte sedimentation rate versus other inflammatory biomarkers: A review

Systemic Immune-inflammation Index in Evaluation of Inflammation in Rheumatoid Arthritis Patients

Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis

Correlation of Interferon-Inducible Chemokine Plasma Levels with Disease Severity in Systemic Sclerosis